Back to MORGAN STANLEY MORGAN STANLEY

XERSXERS
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in XERIS BIOPHARMA HOLDINGS INC

MORGAN STANLEY holds 2.3M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $18.5M as of 2026-Q2. The position was decreased (-9.2% shares). XERS represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$18.5M

Current Shares

2.3M

Total Value Change

+$14.9M

Total Shares Change

+727,172

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.3M
-9.2%
$18.5M0.0%$7.92
0
2026-Q1
Decreased
2.6M
-5.0%
$14.9M0.0%$5.94
0
2025-Q4
Decreased
2.7M
-15.9%
$21.3M0.0%$7.31
0
2025-Q3
Decreased
3.2M
-11.6%
$26.2M0.0%$8.08
0
2025-Q2
Decreased
3.6M
-15.1%
$17M0.0%$4.70
0
2025-Q1
Increased
4.3M
+49.0%
$23.5M0.0%$5.58
39
2024-Q4
Increased
2.9M
+22.2%
$9.8M0.0%$3.38
33
2024-Q3
Increased
2.4M
+46.2%
$6.7M0.0%$2.87
37
2024-Q2
New
1.6M
-
$3.6M0.0%$2.25
37

Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used